ledipasvir 33.75 MG / sofosbuvir 150 MG Oral Pellet
RxNorm concept 2204100, clinical drug (scd). Prescribable name: ledipasvir 33.75 MG / sofosbuvir 150 MG per packet Oral Pellets.
- RxCUI
- 2204100
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2204100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- sofosbuvir 150 MG (SCDC, consists of)
- ledipasvir 33.75 MG (SCDC, consists of)
- Oral Pellet (DF, has dose form)
- ledipasvir 33.75 MG / sofosbuvir 150 MG Oral Pellet [Harvoni] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2204100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2204100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2204100. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.